ARTICLE | Company News
AMAG Pharmaceuticals, 3SBio deal
June 2, 2008 7:00 AM UTC
AMAG Pharmaceuticals granted 3SBio exclusive, Chinese rights to develop and commercialize ferumoxytol to treat anemia in patients with chronic kidney disease (CKD). AMAG will receive $1 million up fro...